HOTH Q1 2020 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOTHHoth Therapeutics, Inc.

$15M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$305

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-4.45

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$23,697

Balance Sheet

Total Assets

$5M

Total Liabilities

$523,312

Stockholders' Equity

$5M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$305	-$7,029	+95.7%
Operating Income	-$2M	-$829,365	-119.0%
Net Income	-$2M	-$829,365	-120.2%